GleamWall
中文EN

FEED ENvue Medical, Inc.

Orthopedic, Prosthetic & Surgical Appliances & Supplies · OTC · SEC CIK 1326706 · Fiscal year ends 12/31

Financial factors as of 2026-06-30 (2026Q2), TTM = sum of the last four quarters

Growth

TTM revenue YoY-17.7%
TTM net income YoY-154.6%
TTM EPS YoY72.9%
Revenue 3-yr CAGR44.2%
Net income 3-yr CAGR—

Margins

Gross margin-26.1%
Operating margin-1,362.7%
Net margin-1,093.6%
FCF margin-609.8%
EBITDA margin-1,313.3%

Returns

ROE-59.1%
ROA-46.9%
ROIC (approx.)-62.7%
Asset turnover0.04x

Leverage & solvency

Liabilities / assets19.9%
Debt / equity0.00x
Current ratio0.66x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.55x
Accruals ratio-20.9%
Payout ratio—
Capex / revenue4.9%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-312024Q32024-09-30
Income statement
Revenue$239,000$653,000$312,000$722,000$494,000$1.02M$444,000$376,000
Cost of revenue$505,000$708,000$682,000$533,000$529,000$656,000$161,000$243,000
Gross profit-$266,000-$55,000-$370,000$189,000-$35,000$369,000$283,000$133,000
R&D expense$510,000$468,000$39,000$221,000$1.02M$530,000$352,000$249,000
SG&A expense$3.50M$2.42M$2.64M$1.40M$2.25M$1.34M$1.13M$673,000
Operating income-$5.47M-$3.71M-$14.81M-$2.25M-$3.98M-$1.85M-$1.37M-$970,000
Interest expense$30,000$36,000—$53,000$144,000$53,000$34,000$33,000
Pretax income-$4.90M-$3.79M-$13.27M$545,000-$3.91M-$1.86M-$1.43M-$995,000
Income tax-$2,000$33,000-$419,000$35,000$62,000$15,000$5,000$3,000
Net income-$4.90M-$3.82M-$12.85M$510,000-$3.97M-$1.87M-$1.43M-$998,000
EBITDA-$5.25M-$3.49M-$14.56M-$1.99M-$3.61M-$1.83M-$1.37M-$970,000
EPS (basic)-1.98-6.88—-0.91-1.03-29.90—-3.56
EPS (diluted)-1.98-6.88—-0.91-1.03-29.90—-3.56
Weighted avg. shares (diluted)6.16M3.29M—858,434484,56662,615—280,318
Balance sheet
Cash & equivalents$1.08M$2.23M$4.22M$6.95M$4.03M$571,000$752,000$1.30M
Receivables$205,000$332,000$289,000$252,000$115,000$358,000$98,000$580,000
Inventory$2.58M$2.27M$2.34M$2.24M$2.21M$2.02M$2.19M$2.25M
Current assets$4.82M$6.20M$7.27M$10.02M$6.89M$3.86M$3.33M$4.38M
PP&E, net$145,000$127,000$119,000$124,000$112,000$125,000$9,000$9,000
Goodwill$29.08M$29.08M$29.08M$38.63M$38.63M$33.91M——
Intangibles$3.96M$4.17M$4.38M$5.28M$5.52M$5.88M——
Total assets$38.41M$39.87M$41.12M$54.38M$51.48M$44.10M$3.63M$4.68M
Current liabilities$7.30M$6.87M$6.66M$11.64M$6.54M$8.20M$2.72M$2.52M
Long-term debt—————$1.25M——
Total debt—————$1.25M——
Total liabilities$7.65M$7.86M$7.63M$11.92M$11.01M$8.43M$3.00M$2.81M
Shareholders' equity$30.76M$32.02M$33.50M$42.46M$40.48M$35.67M$627,000$1.87M
Net debt—————$683,863——
Shares outstanding8.19M3.70M1.10M1.01M787,359734,02537,8942.78M
Cash flow statement
Operating cash flow-$2.69M-$4.31M-$2.68M-$1.97M-$3.38M-$1.34M-$548,000-$836,000
Capital expenditure$27,000$17,000$23,000$28,000$4,000$5,000$0$0
Free cash flow-$2.72M-$4.33M-$2.70M-$2.00M-$3.39M-$1.35M-$548,000-$836,000
Investing cash flow-$27,000-$17,000-$23,000-$28,000-$4,000$143,000$0$0
Financing cash flow$1.59M$2.34M-$34,000$4.92M$6.85M$1.05M$0-$27,000
Depreciation & amortization$219,000$217,000$258,000$257,000$364,000$18,000$0$0
Stock-based compensation——————$191,000$58,000

Free plan shows the latest 8 periods; Pro shows all 50 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.